#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16502	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2032	804.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	957	C	897	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16502	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2032	804.0	0	HET	.	.	.	C451T	.	451	451	C	676	676	C	926	C,T	438,428	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16502	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2032	804.0	0	HET	.	.	.	C207T	.	207	207	C	432	432	C	968	C,T	700,198	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29570	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	802.6	0	.	n	.	0	T695C	SNP	695	695	T	1023	1023	C	885	C,T	814,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29570	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	802.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1966	1966	G	957	G,A	660,229	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29570	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	802.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2299	2299	C	972	C,T	893,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29570	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	802.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2373	2373	A	960	A	898	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29570	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3673	802.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2925	2925	C	878	C	822	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2342	folP	855	855	100.0	folP.l15.c4.ctg.1	1576	147.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1097	1099	AGC	228;225;225	A;G;C	215;212;210	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6016	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3370	177.7	1	SNP	p	S91F	1	.	.	271	273	TTC	564	566	TTC	221;220;218	T;T;C	202;202;203	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6016	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3370	177.7	1	SNP	p	D95G	1	.	.	283	285	GGC	576	578	GGC	212;211;208	G;G;C	198;196;192	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6016	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3370	177.7	1	SNP	p	G95N	0	.	.	283	285	GGC	576	578	GGC	212;211;208	G;G;C	198;196;192	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1914	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1235	153.7	1	SNP	p	G45D	0	.	.	133	135	GGC	419	421	GGC	244;247;245	G;G;C	228;230;230	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	960	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1069	89.4	0	.	n	.	0	A197.	DEL	197	197	A	581	581	A	215	A	210	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	200.5	1	SNP	p	D86N	0	.	.	256	258	GAC	567	569	GAC	229;230;230	G;A;C	207;206;211	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	200.5	1	SNP	p	R87W	0	.	.	259	261	CGT	570	572	CGT	229;229;226	C;G;T	208;209;206	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	200.5	1	SNP	p	S87R	1	.	.	259	261	CGT	570	572	CGT	229;229;226	C;G;T	208;209;206	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	200.5	1	SNP	p	R87I	0	.	.	259	261	CGT	570	572	CGT	229;229;226	C;G;T	208;209;206	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5872	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2916	200.5	1	SNP	p	S88P	0	.	.	262	264	TCC	573	575	TCC	227;227;227	T;C;C	204;204;207	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4690	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2830	165.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1607	1609	GGC	220;218;217	G;G;C	203;201;199	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1240	1242	GCC	242;241;241	G;C;C	222;223;224	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1243	1245	ATG	237;238;235	A;T;G	219;222;220	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1255	1257	ACC	223;221;217	A;C;C	212;212;207	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1255	1257	ACC	223;221;217	A;C;C	212;212;207	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1756	1758	ACC	258;255;258	A;C;C	236;238;241	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1810	1812	GCG	234;234;237	G;C;G	217;215;220	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1810	1812	GCG	234;234;237	G;C;G	217;215;220	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1933	1935	GGT	185;183;183	G;G;T,C	168;167;163,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1942	1944	AGC	189;189;188	A,G;G;C	168,1;168;165	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4560	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2345	193.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1960	1962	CCG	174;173;172	C,G;CG,CGG;G	132,7;124,1;129	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6488	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3208	201.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1689	1691	CCG	245;245;244	C,A,G;C;G	210,1,1;220;211	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2488	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1879	131.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	579	579	C	180	C	160	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3234	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1731	185.5	0	.	p	.	0	G210R	NONSYN	628	630	GGA	931	933	AGA	270;267;267	A,G;G;A	252,1;251;253	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3234	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1731	185.5	0	.	p	.	0	S217G	NONSYN	649	651	AGT	952	954	GGT	269;266;264	G;G;T	249;248;248	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3234	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1731	185.5	1	SNP	p	G120K	1	.	.	358	360	AAG	661	663	AAG	268;267;265	A;A;G,C	246;250;243,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3234	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1731	185.5	1	SNP	p	A121N	1	.	.	361	363	AAC	664	666	AAC	264;261;263	A,G;A;C	245,2;246;247	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3234	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1731	185.5	1	SNP	p	N121D	0	.	.	361	363	AAC	664	666	AAC	264;261;263	A,G;A;C	245,2;246;247	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11278	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4900	229.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1268	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1063	118.3	1	SNP	p	V57M	1	.	.	169	171	ATG	459	461	ATG	280;281;282	A;T;G	262;262;265	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
